Biogen chief sells 12K shares; Sovaldi cures hep C in HIV patients;

@FiercePharma: Tops this weekend: AbbVie finally gets Shire, its low tax base and enough new drugs to protect its future. News | Follow @FiercePharma

@TracyStaton: CVS Caremark lays out case for new specialty-drug pricing approach in JAMA editorial. More | Follow @TracyStaton

@EricPFierce: ICYMI: Teva says it is cooperating with probe by Israel into source of blood infections taking Teva product. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: Allergan plotting 1,500 job cuts as part of restructuring. Release | Follow @CarlyHFierce

> Biogen Idec ($BIIB) CEO George Scangos sold 12,316 shares of the company's stock on the open market in a transaction dated July 16. Report

> Gilead's ($GILD) Sovaldi cures hepatitis C in patients with HIV, a new study says. Report

> Bank Exane BNP Paribas sees at least a 50% chance that Pfizer ($PFE) will return with a sweetened offer for AstraZeneca ($AZN) after its failed takeover earlier this year. Story

> Eli Lilly ($LLY) is expanding its diabetes treatment portfolio in India. Report

> Medicare has scaled back its restrictions on hospice drugs. Report

> India's pharma exports to the U.S. are expected to be high after dropping last year on FDA actions against manufacturers. More

Medical Device News

@FierceMedDev: Stryker delivers positive Q2 numbers but stays mum on inversion. ICYMI Friday | Follow @FierceMedDev

@MichaelGFierce: Delivering breast cancer drug through the skin grants disease prevention. FierceDrugDelivery article | Follow @MichaelGFierce

@VarunSaxena2: Venture capitalist spending bonanza lifts med tech investment in Q2. Report | Follow @VarunSaxena2

@EmilyWFierce: DC journo raises $75K on Kickstarter to fly drones over factory farms, circumvent "ag-gag" laws. More from NPR | Follow @EmilyWFierce

> MIT device could give arthritics and others a helping hand with extra fingers. Story

> Miss Idaho wears insulin pump in swimsuit competition. Item

> Patient groups argue for faster med tech FDA approvals at industry meeting. Article

Biotech News

@FierceBiotech: Will AbbVie now emerge as the next megamerger target? More | Follow @FierceBiotech

@JohnCFierce: New Science Ventures joins the biotech VC boom, plots $100M fund. News | Follow @JohnCFierce

@DamianFierce: Cutting jobs, ditching "unpromising" R&D programs -- $AGN is slowly becoming the company $VRX wants it to be. Just, you know, minus $VRX. | Follow @DamianFierce

@EmilyMFierce: What?! Update on the Found Vials: There Weren't 6; There Were 327. (Not All of Them Were Smallpox.) More from Wired | Follow @EmilyMFierce

> Allergan aims ax at R&D, eliminating 1,500 jobs in bitter takeover fight. Report

> Cerecor raises $16M for PhII study of 'Special K' depression remedy. Article

> J&J partner Aduro grabs an FDA 'breakthrough' nod for its immuno-oncology combo. News

CRO News

> Amid global expansion, India's GVK focuses on clinical development. Story

> CRO Chiltern snags rival Ockham to bolster its oncology footprint. Report

> Post-buyout Harlan inks a CRO partnership with Fluofarma. Article

> Theorem eyes an Indian expansion with latest partnership. Story

> Catalent shoots for $872M in a blockbuster IPO. News

Biotech IT News

> Google-backed service provider gives clients direct control of robot-run lab. Report

> FDA adds recalls API as openFDA initiative gathers pace. News

> Bioinformatics skills help Codexis strike $25M deal with GSK. Story

> Report: Development IT hit hard in Novartis cutbacks. Article

> Novartis and Google team up to commercialize 'smart' contact lenses. Item

Animal Health News

> Seizures in horses in Kentucky focus attention on drug compounding. More

> Virbac H1 sales hurt by Iverhart recall in U.S. Report

> Sanofi's Merial revives heartworm treatment. Article

> Why is there increased activity in animal health IPOs? Item

> France's AB Science warned by FDA for its canine cancer drug promotion. Story

> Merck prods cattle producers to help it test the safety of withdrawn Zilmax. Article

And Finally... A judge has found Pfizer ($PFE) responsible for $1.7 million in sewer payments. Story

Suggested Articles

New "gold standard" data could further increase doctors' confidence in multiple myeloma med Darzalex, Johnson & Johnson says.

Could Monday's cancer buyout be a hint about what Sanofi CEO Paul Hudson will unveil at Tuesday's investor confab? Analysts think so.

Three Samsung execs face up to two years in jail for their roles in destroying data and documents at under-fire affiliate Samsung BioLogics.